Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of MWN109 injection in non-diabetic adults with overweight or obesity
CTR20263082Phase 3Active
- Sponsor
- Shanghai Minwei Biotechnology Co., Ltd.
- Start
- Sep 2026
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of MWN109 in obesity, Overweight, sponsored by Shanghai Minwei Biotechnology Co., Ltd.. Started Sep 2026; status: active.
02
Drugs
MWN109
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on CTR20263082.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20263082.